Top Stories

  • Outpouring of support for boy with brain tumor

    Updated: Sat, Jul 26, 2014

    FOXBOROUGH, Mass. (AP) — A Foxborough boy with an inoperable brain tumor is celebrating his sixth birthday in style after an outpouring of support, much of it coming from strangers around the world. Tens of thousands of birthday cards and packages began streaming in after appeals were posted on social media to help make the boy's birthday extra special. The town's postmaster says Danny Nickerson got more mail on Friday than the entire rest of the town combined. And there was more. On Saturday, first responders from around the region helped Danny celebrate a birthday party at Gillette Stadium, where he attended a practice of the New England Patriots and even got to meet some of the players.

  • Dream coach Cooper has surgery for tongue cancer

    Updated: Fri, Jul 25, 2014

    ATLANTA (AP) — Atlanta Dream coach Michael Cooper has had surgery for tongue cancer. The WNBA team said Friday that Thursday's procedure was successful and Cooper "will be back coaching soon." The team announced Monday that the 58-year-old Cooper has early stage tongue cancer. Assistant coach Karleen Thompson is filling in. Cooper is in his first season with Atlanta. His team leads the Eastern Conference with a 15-7 record. Atlanta plays Chicago on Friday night. Cooper won five NBA titles as a shooting guard with the Los Angeles Lakers during the "Showtime" era from 1978-90. He coached the Los Angeles Sparks to two WNBA titles and won one NBA Development League championship with Albuquerque.

  • Bicyclists gather in Southport for cancer ride

    Updated: Fri, Jul 25, 2014

    SALISBURY, Conn. (AP) — Close to 1,000 bicyclists are gathering in Salisbury for a 100-mile ride to help cancer survivors. The CT Challenge ride begins in Lakeville on Friday and finishes in Westport. There also will be rides of between 10 and 100 miles on Saturday, all which start and finish at the Fairfield County Hunt Club in Westport. Former Boston Red Sox and New York Mets manager Bobby Valentine is co-chairing the event along with 11-year-old Maya Oberstein, a cancer survivor. It's the 10th anniversary of the ride, which has raised $10 million for cancer survivors. The money raised goes to the Center for Survivorship in Southport, which provides support services such as nutrition classes and physical ther

  • LSU enrolling patients in new kind of drug test

    Updated: Fri, Jul 25, 2014

    NEW ORLEANS (AP) — LSU Health Sciences Center says people with a common, hard-to-treat kind of lung cancer can join a new national trial to test drugs faster. Patients with advanced squamous (SKWAY-muhs) cell lung cancer can enroll at LSU cancer centers in New Orleans, Houma, Covington and Baton Rouge. Most such clinical trials test one drug that may affect one cancer gene. The Lung Cancer Master Protocol, or Lung-MAP, gives full gene tests, with five new drugs available. Doctors will assign each patient to the test of the drug with the best chance of helping. Organizers want to enroll 10,000 people nationwide. They say 85 locations began enrollment in June and 169 more by Wednesday. LSU is among 24 hospitals a

  • More girls now getting cervical cancer vaccine

    Updated: Thu, Jul 24, 2014

    NEW YORK (AP) — The government is reporting an increase in teen U.S. girls getting a controversial cervical cancer vaccine — but it's not much of a bump. Last year's rise follows a couple of years when the HPV vaccination rate was flat. For girls ages 13 to 17, the rate is now up to about 38 percent from 33 percent. The CDC on Thursday reported the latest rates for the vaccine that protects against human papillomavirus, or HPV. The sexually transmitted bug can cause cervical cancer, genital warts and other illnesses. The vaccine has been available since 2006. ___ Online: CDC: http://www.cdc.

  • Bristol 2Q net drops on lower drug sales, charges

    Updated: Thu, Jul 24, 2014

    NEW YORK (AP) — Bristol-Myers Squibb Co.'s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations. The maker of arthritis medicine Orencia and schizophrenia drug Abilify also lowered its profit forecast for 2014 by 20 cents, to a range of $1.50 to $1.60, saying it expects more restructuring charges and asset writedowns. The New York-based drugmaker said Thursday that net income was $333 million, or 20 cents per share, down from $536 million, or 32 cents per share, a year earlier.

  • Turkish citizen pleads guilty in drug fraud case

    Updated: Tue, Jul 22, 2014

    ST. LOUIS (AP) — A Turkish citizen pleaded guilty Tuesday to federal charges for smuggling counterfeit and adulterated cancer treatment drugs into the United States. Ozkan Semizoglu of Istanbul entered the plea in U.S. District Court in St. Louis. Sentencing is Oct. 28. Semizoglu and a second Turkish citizen, Sabahaddin Akman, were indicted in January. Akman has pleaded not guilty. He is scheduled for trial on Sept. 2. Federal prosecutors say the men smuggled three shipments from Turkey to Chesterfield, Missouri, a St. Louis suburb. They were arrested in Puerto Rico soon after the indictment. According to the plea agreement, Semizoglu falsely labeled shipments of drugs as "gifts" or "documents" to conceal their

  • Music festival raises $11,000 for cancer center

    Updated: Tue, Jul 22, 2014

    MONTPELIER, Vt. (AP) — Officials at Montpelier's National Life Group say the inaugural Do Good Festival held on the grounds of the company's headquarters raised almost $11,000 for a cancer treatment center at the area hospital. The money raised by the festival will benefit Branches of Hope, the Cancer Patient Fund at Central Vermont Medical Center's National Life Cancer Treatment Center. About 1,500 people attended the Saturday event in Montpelier. Branches of Hope helps with the basic living expenses and emergency and special needs of people receiving cancer care.

  • Ark. university awarded $1.5M for cancer research

    Updated: Tue, Jul 22, 2014

    FAYETTEVILLE, Ark. (AP) — Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that improve a patient's immune response against tumors. The goal of the five-year grant is to help clinicians attack hidden metastatic tumors and prevent cancer recurrence. Metastasis is the development of secondary malignancy away from the primary site of cancer. David Zaharoff, an assistant professor of biomedical engineering and the principal investigator for the project, says metastasis — not a patient's primary tumor — kills about 90 percent of cancer patients.

  • Dream coach Michael Cooper has tongue cancer

    Updated: Mon, Jul 21, 2014

    ATLANTA (AP) — Atlanta Dream coach Michael Cooper has early stage tongue cancer and has taken a leave from the WNBA team. He will have surgery this week at Winship Cancer Institute of Emory University in Atlanta and a full recovery is expected, the Dream said Monday. The 58-year-old coach is expected to miss about two weeks, with assistant coach Karleen Thompson filling in. Atlanta plays at Minnesota on Tuesday. "I'm fortunate that my condition was diagnosed early, and this episode illustrates the importance of screening and early detection," Cooper said. "I know the team will be in good hands with coach Thompson at the helm during my absence, and I look forward to returning to the court soon." Cooper is in his

  • 7 scientists awarded grants to study cancer cures

    Updated: Sat, Jul 19, 2014

    FALMOUTH, Maine (AP) — The Maine Cancer Foundation is giving seven scientists grants totaling $839,000 to study the origins and potential cures for cancer. Recipients include Drs. Julie Wells and Archana Gopalan from The Jackson Laboratory, who will receive $50,000 each for studies on lung cancer and brain cancer respectively. Dr. Andre Khalil of the University of Maine, studying breast cancer and Dr. Leif Oxburgh from Maine Medical Center Research Institute, studying kidney cancer, each received nearly $180,000 to further their research. Dr. Leonard Shultz of The Jackson Laboratory received nearly $170,000 to develop a genetically modified mouse for leukemia studies. Dr. Jennifer Trowbridge from The Jackson Lab

  • New leader says Komen has eye on future

    Updated: Fri, Jul 18, 2014

    FORT WORTH, Texas (AP) — The new leader of the Susan G. Komen for the Cure organization says it has moved on from the controversy that erupted 2½ years ago over its decision, quickly reversed in an onslaught of criticism, to stop giving grants to Planned Parenthood for breast cancer screenings. "I think we as an organization have moved past it and I think that's the important thing — that we keep focusing on our mission," said Judy Salerno, who was named Komen's president and chief executive officer last June. "And frankly and I hope that people who still have some lingering concerns about us will know that we are focused: We have a singular focus, and that's saving lives from breast cancer.

  • Judge halts company's claims about spray product

    Updated: Fri, Jul 18, 2014

    DES MOINES, Iowa (AP) — A judge has barred a Las Vegas company from calling Iowa residents and claiming to sell a human growth hormone product that kills cancer cells. Polk County District Court Judge Michael D. Huppert issued an injunction Thursday against Americare Inc., its owner and two telemarketers. The company does business as Americare Health. Attorney General Tom Miller says the state's consumer protection division recorded a phone call showing telemarketers making misleading claims about an oral spray's effects on cancer and other serious diseases and conditions. The company sells the spray for $249 per bottle. The injunction requires that defendants refrain from collecting any payments for past sales from I

  • A machine that can 'smell' cancer

    Published: Wed, Jul 16, 2014

    It's the second most common cancer for men worldwide, but prostate cancer remains difficult to diagnose, with standard blood tests criticized for delivering a high rate of false positives. But in a study presented in May this year, trained detection dogs were able to identify prostate cancer from a few sniffs of a urine sample with a staggering 98% accuracy, with few false positives. Although the study is by no means conclusive, it joins a growing body of research suggesting dogs could be able to smell out cancers.

  • West Virginia editorial roundup

    Updated: Tue, Jul 15, 2014

    Recent editorials from West Virginia newspapers: July 15 The Register-Herald, Bleckley, West Virginia, on being willing to help: Outsiders can say what they will about West Virginians — but they can't say we're stingy. Time after time after time, we band together to help our neighbors out of a jam, aid someone down on their luck or otherwise in a bad way. Is there a serious illness in the family? Watch for a bean dinner to help with expenses. A family is burned out of their home? Pretty soon they will have all the clothes and household goods they need, courtesy of donations from around the community. West Virginians want to help. It's our nature. Opportunities to continue showing that gen

  • FDA weighs cancer risk of fibroid removal devices

    Updated: Fri, Jul 11, 2014

    WASHINGTON (AP) — Federal health advisers say there is little to no evidence that a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body. The panel of Food and Drug Administration experts also said Friday that women who do undergo the procedure should sign a written consent form stating they understand the serious risks of laparoscopic power morcellation, in which electronic tools are used to grind tissue and remove it through a small incision in the abdomen. Surgeons developed the technique as an alternative to traditional surgery, which requires a larger incision that often results in more bleeding and longer hospital stays.

  • Pediatric doctor in child porn case gets prison

    Updated: Fri, Jul 11, 2014

    COLUMBUS, Ohio (AP) — A former top pediatric cancer doctor was sentenced to a year and one day in federal prison Friday following his guilty plea to a charge of accessing child pornography. Before sentencing, Christopher Pelloski told federal Judge James Graham he had harmed children, shamed his family and burdened colleagues in the pediatric cancer field by committing a crime that meant he would never practice medicine again. Pelloski, the former director of Ohio State University's pediatric cancer radiation program, said he also added to the pain felt by families whose children he was treating, since they had to wonder if he had ever harmed their children. "I've generated a lot of harm and I've hurt those who loved

  • Japan musician Ryuichi Sakamoto has throat cancer

    Updated: Fri, Jul 11, 2014

    TOKYO (AP) — Japanese musician Ryuichi Sakamoto, who shared an Oscar for Bernardo Bertolucci's "The Last Emperor" score, has been diagnosed with throat cancer and has canceled his upcoming performances to focus on his health. "I promise to return after a full recovery," Sakamoto, 62, said Thursday on his official website. He apologized for bowing out of his upcoming events, saying he would not be able to attend the First Sapporo International Art Festival, which starts later this month. He said he was also "deeply upset" at having to cancel a July 30 concert for the Park Hyatt Tokyo's 20th anniversary, where he had planned to unveil new material. At "the end of June, I was diagnosed with throat cancer," he said on his

  • New exec director named for breast cancer group

    Updated: Thu, Jul 10, 2014

    MANCHESTER, Vt. (AP) — A nonprofit organization that raises money to fight breast cancer has a new executive director for Vermont and New Hampshire. Terry Farkas has been named to the position at Komen Vermont-New Hampshire. She is a longtime volunteer for the organization. The group organizes the Susan G. Komen Race for the Cure and other events.

  • Secondhand smoke as harmful to pets as people

    Updated: Wed, Jul 9, 2014

    LOS ANGELES (AP) — Ten years ago, Shirley Worthington rushed Tigger to the vet when the dog's mouth started bleeding. When she was told he had cancer, she knew to blame her heavy smoking, an addiction she couldn't kick until after her pet died. Secondhand smoke can cause lung and nasal cancer in dogs, malignant lymphoma in cats and allergy and respiratory problems in both animals, according to studies done at Tufts University's School of Veterinary Medicine in Massachusetts, Colorado State University and other schools. The number of pets that die each year from tobacco exposure isn't available, but vets know from lab tests and office visits that inhaling smoke causes allergic reactions, inflammation and nasal and pulmonary